Our Company

In 2011, Sight Sciences was founded to change the way the practice of ophthalmology and optometry thinks about and treats the leading causes of eye disease.

Supported by leading medical technology and private equity investors, Sight Sciences operates two business lines: surgical and non-surgical systems. Its surgical product portfolio consists of the OMNI™ Glaucoma Treatment System for use by ophthalmologists. Its non-surgical product portfolio consists of the TearCare® technologies for use by ophthalmologists and optometrists.